Toshiba Medical Systems Corporation acquires Olea Medical SA

Toshiba Medical Systems Corporation has completed its acquisition of software application manufacturer Olea Medical SA, the company announced this week. The final step was gaining approval of the deal from the French Ministry of Economy.

Olea Medical was founded in France in 2008 and specializes in vendor-neutral post-processing applications for both MRI and CT. Toshiba will now put more focus on its MRI business as a result of the deal.

“This partnership means we will benefit from both Toshiba’s and Olea’s strengths to accelerate innovation and enhance our global presence,” Toshio Takiguchi, president and CEO of Toshiba Medical Systems Corporation, said in a statement. “Through the integration of both R&D teams, we believe we could bring the innovative solutions and products to play an important role in the development of MRI systems.”

“This is great news for Olea’s customers and our fabulous team, and we are happy and proud to join the Toshiba family,” Fayçal Djeridane, Olea Medical SA president and CEO, said in the same statement. “We are convinced this is the right strategy to pursue our commitment to provide a widely accessible, complete package of simple, safe, fast and accurate tools for full-body image post-processing, in order to help doctors improve the diagnosis and follow-up process for patients’ benefit worldwide.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.